Abstract. Ulcerative colitis is characterized by crypt infiltration particularly of neutrophils. However, it is not known whether it reflects a primary crypt disorder or a secondary inflammatory response. In this study, we analyzed the expression profiles of histologically normal crypts microdissected from formalin-fixed biopsies of early stage ulcerative colitis. Total RNAs were extracted, amplified, and applied to Affymetrix GeneChip ® X3P Array. For the control, similar crypts from nonspecific colitis biopsies were applied. A total of 353 (4.3%) and 111 (1.4%) genes were >3 times up-, and down-regulated in ulcerative colitis. Up-regulated genes included FCGBP (Fc fragment of IgG binding protein), cyclophilin A, chemokine (C-X-C motif) ligand 3, and genes associated with lipid metabolism. Down-regulated genes included APOA4 (apolipoprotein A-IV), cylindromatosis, BCL2-like 10, claudin 8, and numerous transcriptional regulators. FCGBP and APOA4 have been implicated in ulcerative colitis previously. Our data show differential expression in the crypt epithelia of ulcerative colitis before active inflammation is initiated, suggesting primary crypt abnormalities that might be implicated in the pathogenesis of ulcerative colitis.
Introduction
Ulcerative colitis is a chronic inflammatory bowel disease of unknown pathogenesis (1) . Diverse genetic backgrounds and aberrant immune regulations have been associated with ulcerative colitis (2) . Ulcerative colitis consists of mucosal inflammation with characteristic crypt abscesses (3) (4) (5) (6) (7) (8) . The infiltration of neutrophils has been taken as a parameter of disease activity (9) (10) (11) (12) .
In ulcerative colitis, neutrophils appear to infiltrate specifically into the crypts, suggesting that they might target the crypt epithelium. It is particularly evident in early stage biopsies, often showing scattered crypt infiltrates in otherwise unremarkable mucosa. The crypt targeted infiltration is consistent with previous studies of impaired crypt epithelial barriers in ulcerative colitis (13, 14) . However, it is not clear whether the barrier disruption is a primary disorder or secondary to inflammation (15) . Inflammatory cytokines have been shown to down-regulate tight junction proteins secondarily (16, 17) . Thus, a critical question remains whether the crypt epithelia have pre-existing abnormalities before active infiltration and/or regenerative changes occur.
Expression profiling analyses have reported candidate genes which might be associated with ulcerative colitis (18) (19) (20) (21) (22) (23) (24) (25) . However, DNA microarray data using whole tissue samples of gastrointestinal tracts is difficult to interpret because of considerable noise from various inflammatory infiltration, stromal reaction, and regenerative epithelial change (26) . Recently, a few studies of expression profiling or pattern analysis of isolated inflammatory cells have been reported (27, 28) . However, no crypt-specific expression profiling has been reported in ulcerative colitis.
Colonoscopic biopsies are routinely fixed in formalin and processed for histopathologic examination. Formalin-fixation provides excellent preparations for the recognition of subtle pathologic changes of crypt epithelium. Furthermore, it would make retrospective studies possible using remnant paraffin blocks in pathology files. However, it causes extensive base modification of nucleic acids (29) , which makes it difficult to recover RNAs for expression profiling. The emerging technology has improved considerably the expression profiling of formalin-fixed tissue samples (30, 31) . Recently, we reported a simple and reproducible procedure of RNA extraction and amplification which successfully detected sequential expression changes in the gastric adenoma/ carcinoma sequence (32) .
In this study, we analyzed the expression profiles of histopathologically normal crypts microdissected from formalinfixed, paraffin-embedded biopsies of ulcerative colitis, and a comparison was made with the controls of similar normal crypts in non-specific colitis. Our data show considerable differential expression suggesting that aberrant crypt regulation is implicated in the pathogenesis of ulcerative colitis.
Materials and methods
Patients and biopsies. Three biopsies of ulcerative colitis were selected following guidelines of the Institutional Review Board of Asan Medical Center, Seoul, Korea. They were from a 34-year-old female and 46-, and 55-year-old male patients who were either first diagnosed as having ulcerative colitis or examined for recurrent clinical symptoms. Clinical and laboratory diagnostic criteria for ulcerative colitis were met in all cases as follows (33) : i) a typical history of diarrhea or blood and pus, or both, in the stool for longer than 4 weeks; ii) a typical colonoscopic picture with diffusely granular, friable, or ulcerated mucosa without rectal sparing or skip lesions. Biopsies were diagnostic of ulcerative colitis of early stage showing typical crypt abscesses in mild chronic inflammation. No crypt distortion or regenerative change was evident. For the control, 3 biopsies of nonspecific colitis showing mild inflammation of similar degree were selected. Biopsies were taken from 31-, 49-, and 53-year-old males who had abdominal discomfort and intermittent diarrhea, which did not meet the above criteria. No specific colonoscopic features of ulcerative colitis were present.
Microdissection of crypts.
Biopses were fixed immediately in 10% buffered-formalin and routinely processed for paraffinembedding. After pathological examinations, additional step sections of 8-μm thickness were prepared. To avoid RNase contamination, slides and instruments were autoclaved and all solutions were freshly made using DEPC-treated water. From each biopsy, 100 histologically normal crypts were microdissected using the AutoPix laser capture microscope system (Arcturus Bioscience, Inc., Mountain View, CA), as described previously (32) . No inflammatory cells were included. To ensure the quality of RNA samples and minimize individual variations, microdissected samples of ulcerative colitis and controls were pooled respectively.
RNA extraction. Microdissected samples were suspended in 200 μl digestion buffer [2% SDS, 10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA], and incubated at 70˚C for 1 h to relieve the formalin-induced modifications. Then, 3 μl proteinase K (30 μg/μl, Intron Biotech., Songnam, Korea) was added, and incubated again at 55˚C for 1 h. RNAs were extracted twice using TRIzol reagents (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The extracted RNAs were precipitated in isopropanol with 5 μg linear acrylamide (Ambion, Austin, TX), and the RNA pellets were resuspended in 10 μl nuclease-free water (Ambion). The quality of extracted RNAs was checked using denaturing agarose gel. The amount of extracted RNA samples and/or amplified RNA was measured using RiboGreen RNA quantitation kit (Molecular probes, Eugene, OR) according to the manufacturer's protocol. Each measurement was duplicated, and the average values were taken.
Affymetrix GeneChip analysis. Amplifications were performed using Affymetrix two-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA) according to the manufacturer's instructions. To synthesize the first-strand cDNA, 15 ng total RNA was incubated with T7-oligo(dT) primer and SuperScript II reverse transcriptase at 42˚C for 1 h. After incubating the mixture at 70˚C for 10 min, E. coli DNA polymerase I and RNase H were added and incubated at 16˚C for 2 h to produce the second-strand cDNAs. First-cycle cRNA synthesis was made by MEGAscript T7 kit (Ambion) by incubating the sample with reagents at 37˚C for 16 h. cRNAs were purified by GeneChip cleanup module (Affymetrix) according to manufacturer's instructions. Purified cRNAs were used for the second-cycle cDNA synthesis. After the incubation with random primer and SuperScript II at 42˚C for 1 h, RNase H was added to the mixture and incubated at 37˚C for 20 min additionally. E. coli DNA polymerase I was added and incubated at 16˚C for 2 h. Then, T4 DNA polymerase was added and incubated at 16˚C for an additional 10 min.
Purified cDNAs were used for the subsequent in vitro transcription (IVT) labeling reaction using GeneChip IVT labeling kit (Affymetrix) according to manufacturer's instruction. cRNAs were fragmented by incubation at 94˚C for 35 min. Fragmented cRNAs were hybridized to Affymetrix GeneChip ® Human X3P Array at 45˚C for 16 h. Washing and staining the array was performed by GeneChip Fluidics 450 according to the manufacturer's instructions. Scanning of the array was done using Affymetrix GeneChip Scanner 3000. Expression signals were analyzed using Affymetrix GeneChip software MAS5.0 and Microsoft Excel (Microsoft Corp., Redmond, WA). The complete data set is publicly available in the NCBI Gene Expression Omnibus (http://www.ncbi. nlm.nih.gov/geo/) through the accession number: GSE3801.
Immunohistochemistry. Five ulcerative colitis and control biopsies were immunostained as described previously (34) . Immunohistochemical staining was done using a Benchmark Autostainer (Ventana Medical Systems Inc., Tucson, AZ), according to manufacturer's instructions. For the antigen retrieval, slides were heated at 100˚C for 30 min. Rabbit polyclonal anti-cyclophilin A (Santa Cruz Biotechnology, Santa Cruz, CA) was applied at the dilution of 1:100. The ABC complex was developed using diaminobenzidine as chromogen, and the slides were counterstained with hematoxylin.
Results

Histopathology and microdissection.
Mucosal biopsies of ulcerative colitis showed typical pathologic features with scattered crypt abscesses with epithelial damage (Fig. 1A) . However, adjacent uninvolved crypts did not show infiltration or regenerative change (Fig. 1B) . In nonspecific colitis, no crypt abscess was present. There were minimal chronic inflammatory infiltration in lamina propria of both ulcerative colitis and nonspecific colitis control. Histopathologically normal crypts were microdissected from ulcerative colitis ( Fig. 1C and D); they were indistinguishable from those of nonspecific colitis ( Fig. 1E and F) . No inflammatory cells were included in the microdissected crypts.
RNA extraction and amplification. From total 300 crypts of ulcerative colitis crypts and controls, 81 and 89 ng total RNAs were extracted, respectively, then 15 ng RNA was applied to the amplification as described in Materials and methods, yielding 7.4 and 6.9 μg of aRNA for ulcerative colitis and control, respectively. For the expression profiling, labeled aRNAs were applied to Affymetrix GeneChip Human X3P Arrays.
DNA microarray analysis. Affymetrix GeneChip Human X3P
Array was specifically designed for whole-genome expression profiling of formalin-fixed, paraffin-embedded samples. To detect amplified signals efficiently, the majority of probe sets on the arrays were selected from the 300 bases at the extreme 3'-end of the transcripts.
Among 61,359 gene spots in the microarray, 14,429 (23.5%) and 10,036 (16.4%) spots were hybridized significantly for ulcerative colitis and control, respectively (detection p<0.05). A total of 8,198 gene spots (13.4%) was hybridized significantly in both ulcerative colitis and controls. After sorting out redundant spots for a given gene, 353 (4.3%) and Table I . Up-regulated genes in ulcerative colitis. 111 (1.4%) genes were >3 times up-, and down-regulated in ulcerative colitis (Tables I and II) . Among up-regulated genes, the top was X (inactive)-specific transcript (XIST) ( Table I) . XIST is expressed only in inactive X chromosomes, indicating a female origin (35) . There was a female patient included in our ulcerative colitis group, while the control group consisted of only males. Thus, the 'up-regulation' of XIST served as an internal control in this study.
Some normally expressed genes in colon were up-regulated considerably: chloride channel calcium activated family member 1 (CLCA1), Fc fragment of IgG binding protein (FCGBP), Á-actin (ACTG1), trefoil factor 3 (TFF3), carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7), and annexin 4 (ANXA4). FCGBP has been reported to be up-regulated in ulcerative colitis (36) . It is a mucin-like, non-Fc receptor protein which was implicated in immunological defense of mucosa (37) . Annexin 4 is expressed by only epithelial cells.
Genes implicated in inflammation were up-regulated: peptidylprolyl isomerase A (cyclophilin A) (PPIA), nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor · (NFκBI·), chemokine (C-X-C motif) ligand 3 (CXCL3), CXCL1, and CXCL2. Cyclophilin A has been reported to be a chemotactic factor for neutrophils (38, 39) . The up-regulation suggested an implication in the neutrophildominant targeted crypt infiltration in ulcerative colitis.
Many lipid metabolism-associated genes were also upregulated: Farnesyl-diphosphate farnesyltransferase 1 (FDFT1), acyl-CoA synthetase long-chain family member 3 (ACSL3), fatty acid binding protein 1, liver (FABP1), low density lipoprotein receptor (LDLR), and fatty acid binding protein 5 (FABP5). Anti-apoptotic genes baculoviral IAP repeat-containing 6 (BIRC6) and ADP-ribosylation factorlike 6 interacting protein (ARL6IP), and cell junction/ cytoskeleton genes E-cadherin (CDH1), tight junction protein 2 (TJP2), and keratin 20 (KRT20) were also up-regulated.
Down-regulated genes included the ones implicated in lipid metabolism such as apolipoprotein A-IV(APOA4) and membrane-bound transcription factor protease site 1 (MBTPS1) ( Table II) . APOA4 has been implicated in the protection against inflammatory bowel disease in mice suggesting an anti-inflammatory role. Vowinkel et al reported that APOA4-knockout mice were susceptible to experimentally induced colitis, which was protected by exogenous administration of APOA4 (40) . Cylindromatosis (CYLD) negatively regulates NF-κB signaling by deubiquitination (41) . Downregulation of CYLD might also be implicated in enhanced inflammation. Tight junction protein claudin 8 was downregulated, suggesting an implication in the crypt epithelial barriers in ulcerative colitis. Apoptosis-related genes, APG12 autophagy 12-like (APG12L), BCL2-like 10 (BCL2L10) were also down-regulated.
Immunohistochemistry. We investigated the expression of cyclophilin A using immunohistochemistry. In nonspecific colitis control, crypts in the basal compartment were mildly immunostained for cyclophilin A (Fig. 1G) . Under the same staining conditions, crypt epithelial cells were strongly immunostained in ulcerative colitis (Fig. 1H) , concurring with the expression data. Goblet cells were not immunostained. Chronic inflammatory cells were immuno-stained similarly in ulcerative and nonspecific colitis.
Discussion
We have shown differential expressions in the crypts of ulcerative colitis before the infiltration. We were able to obtain reliable gene expression profiling of microdissected crypts from formalin-fixed, paraffin-embedded tissue using a relatively simple procedure. Our RNA extraction method including sequential heating and proteinase K digestion has been shown to provide quality samples for DNA microarray analysis (32) . Results are significantly better in terms of the amount and quality of amplified signals than the ones, for instance, obtained using a commercially available Paradise™ Reagent System (Arcturus Bioscience) which is proposed for the application to formalin-fixed, paraffin-embedded tissue (Lee I, et al, unpublished data). Using our method, ~100 cross-sectioned crypts were enough to provide RNA for the hybridization to a microarray.
Because morphologically normal crypts from early stage ulcerative colitis were microdissected from well-prepared sections, data noise from inflammatory cell contamination and/ or secondary regenerative epithelial changes were largely eliminated. Mitoses in crypts were minimal in both ulcerative colitis and control, suggesting that nonspecific expressions related to cell proliferation were virtually excluded. The control ONCOLOGY REPORTS 16: 663-670, 2006 Table I. Continued. Table II . Down-regulated genes in ulcerative colitis. For this study, a standard linear amplification method was adopted using an Affymetrix kit. However, the procedure including two-cycle amplification would inevitably induce deviation of data the extent of which is not clear in this study. Nevertheless, there is evidence that support the reliability of our data. The fact that female-origin XIST was the most upregulated gene strongly suggests the fidelity of our data serving as an internal control. The immunohistochemical staining of cyclophilin A also supported the expression data. Among the differentially expressed genes, those being implicated in ulcerative colitis such as APOA4 and FCGBP were included. Another indirect evidence of the reproducibility is the redundancy of signals. In the microarray, some genes are represented by redundant spots in which seeded oligonucleotides are not necessarily identical. For instance, 10 Á-actin and 6 cyclophilin A spots were included in the differential expression, suggesting the reproducibility. Together, it is suggested that reliable expression profiling data could be obtained using a reasonable number of microdissected cells from routinely processed biopsies, although there is considerable loss of signals in quantity. The amount of data obtained from formalin-fixed biopsies appear to be reduced to about half of the fresh sample counterparts using our procedure (Lee I, et al, unpublished data). The obtainable data may be extended by increasing the load and/or repeated applications.
The up-regulation of cyclophilin A in normal crypts might suggest an implication in the pathogenesis. Cyclophilin A is an intracellular protein that is known as a receptor for the immunosuppressive drug, cyclosporine A (38,39). Cyclophilin A is elevated in inflammation and may induce neutrophil chemotaxis in vivo and in vitro. The neutrophil chemotaxis concurs with the crypt-specific infiltration in ulcerative colitis. The pathobiological role of Cyclophilin A and other inflammation-associated genes needs further characterization in ulcerative colitis.
Numerous genes associated with lipid metabolism were differentially expressed, suggesting a pathogenic association of aberrant lipid regulation with ulcerative colitis. It has been shown that APOA4 has a protective effect against experimentally induced inflammatory bowel disease in mice (40) . The up-regulation of FABP1 was concurrent with a previous expression profiling study (20) .
Down-regulation of claudin 8 might be consistent with previous studies of altered epithelial barriers of colonic mucosa in ulcerative colitis (13) (14) (15) . Claudin 8 is a member of a large family of tight junction integral membrane protein, and is suggested to have a cation barrier function (42) . In our data, claudins 4, 12, and 15 were not differentially expressed, and claudin 7 was up-regulated <3 times. Other claudins were not significantly hybridized. Tight junction protein 2 (zona occludens 2) and adherent junction protein E-cadherin were up-regulated. It is possible that only a limited number of tight junction protein(s) might be down-regulated in ulcerative colitis while other junction proteins show compensatory up-regulation.
Taken together, the differential expression in uninflamed crypt epithelia suggests innate disorders of crypt regulation in ulcerative colitis. Differentially expressed genes of various functions might suggest a complex pathogenesis encompassing abnormal epithelial barrier and aberrant immune regulation (Kim et al, unpublished data) . As diagnostic biopsies may be applied readily, we expect that the expression profiling will be extended for various purposes such as sequential progression of subtle diseases and treatment effects. Table II. Continued.
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